4.8 Review

Notch3: from subtle structural differences to functional diversity

期刊

ONCOGENE
卷 27, 期 38, 页码 5092-5098

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.230

关键词

Notch receptor structure; Notch3; Jagged1; oncogenic pathways; T-cell leukemia

资金

  1. Associazione Italiana per la Ricerca sul Cancro (AIRC)
  2. Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)

向作者/读者索取更多资源

The Notch3 gene was identified, at the beginning of 90s, as the third mammalian Notch and was initially reported as being expressed in proliferating neuroepithelium. Since then, increasing evidence has demonstrated a number of structural and functional differences between Notch3 and both Notch1 and Notch2, which exhibit the highest structural similarity among the four mammalian Notch receptors. Possibly due to its more restricted tissue distribution, targeted deletion of murine Notch3 does not lead to embryonic lethality as is observed with targeted deletion of Notch1 and Notch2. However, genetic mutation, amplification and deregulated expression of Notch3 have been correlated with the disruption of cell differentiation in transgenic mice and to development of diseases in mice and humans. This review discusses the possible relationships between the structural differences and the nonredundant roles that Notch3 plays in the pathogenesis of the human disease cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy and in the regulation of murine T-cell differentiation and leukemogenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest

Giulia Diluvio, Francesca Del Gaudio, Maria Valeria Giuli, Giulia Franciosa, Eugenia Giuliani, Rocco Palermo, Zein Mersini Besharat, Maria Gemma Pignataro, Alessandra Vacca, Giulia d'Amati, Marella Maroder, Claudio Talora, Carlo Capalbo, Diana Bellavia, Saula Checquolo

ONCOGENESIS (2018)

Article Oncology

Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation

Laura Antonucci, Laura Di Magno, Davide D'Amico, Simona Manni, Silvia Maria Serrao, Fiorella Di Pastena, Rosa Bordone, Zuleyha Nihan Yurtsever, Miriam Caimano, Marialaura Petroni, Alessandra Giorgi, Maria Eugenia Schinina, John R. Yates, Lucia Di Marcotullio, Enrico De Smaele, Saula Checquolo, Carlo Capalbo, Enzo Agostinelli, Marella Maroder, Sonia Coni, Gianluca Canettieri

INTERNATIONAL JOURNAL OF ONCOLOGY (2019)

Review Cell & Tissue Engineering

Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells

Simona Ceccarelli, Francesca Megiorni, Diana Bellavia, Cinzia Marchese, Isabella Screpanti, Saula Checquolo

STEM CELLS INTERNATIONAL (2019)

Article Oncology

Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL

Luca Tottone, Nadezda Zhdanovskaya, Alvaro Carmona Pestana, Michele Zampieri, Fabrizio Simeoni, Sara Lazzari, Valeria Ruocco, Maria Pelullo, Paola Caiafa, Maria Pia Felli, Saula Checquolo, Diana Bellavia, Claudio Talora, Isabella Screpanti, Rocco Palermo

FRONTIERS IN ONCOLOGY (2019)

Review Immunology

Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression

Georgia Tsaouli, Elisabetta Ferretti, Diana Bellavia, Alessandra Vacca, Maria Pia Felli

JOURNAL OF IMMUNOLOGY RESEARCH (2019)

Review Oncology

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype

M. V. Giuli, E. Giuliani, I. Screpanti, D. Bellavia, S. Checquolo

JOURNAL OF ONCOLOGY (2019)

Article Oncology

Kras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance

Maria Pelullo, Francesca Nardozza, Sabrina Zema, Roberta Quaranta, Carmine Nicoletti, Zein MersiniBesharat, Maria Pia Felli, Bruna Cerbelli, Giulia d'Amati, Rocco Palermo, Carlo Capalbo, Claudio Talora, Lucia Di Marcotullio, Giuseppe Giannini, Saula Checquolo, Isabella Screpanti, Diana Bellavia

CANCER RESEARCH (2019)

Review Genetics & Heredity

Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer

Maria Pelullo, Sabrina Zema, Francesca Nardozza, Saula Checquolo, Isabella Screpanti, Diana Bellavia

FRONTIERS IN GENETICS (2019)

Article Biochemistry & Molecular Biology

PLK1 targets NOTCH1 during DNA damage and mitotic progression

Carlo De Blasio, Azzurra Zonfrilli, Matteo Franchitto, Germano Mariano, Samantha Cialfi, Nagendra Verma, Saula Checquolo, Diana Bellavia, Rocco Palermo, Dario Benelli, Isabella Screpanti, Claudio Talora

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Current Trends in ATRA Delivery for Cancer Therapy

Maria Valeria Giuli, Patrizia Nadia Hanieh, Eugenia Giuliani, Federica Rinaldi, Carlotta Marianecci, Isabella Screpanti, Saula Checquolo, Maria Carafa

PHARMACEUTICS (2020)

Article Oncology

Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response

Maria Valeria Giuli, Giulia Diluvio, Eugenia Giuliani, Giulia Franciosa, Laura Di Magno, Maria Gemma Pignataro, Luca Tottone, Carmine Nicoletti, Zein Mersini Besharat, Giovanna Peruzzi, Maria Pelullo, Rocco Palermo, Gianluca Canettieri, Claudio Talora, Giulia D'Amati, Diana Bellavia, Isabella Screpanti, Saula Checquolo

ONCOGENESIS (2020)

Review Biochemistry & Molecular Biology

MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia

Martina Del Gaizo, Ilaria Sergio, Sara Lazzari, Samantha Cialfi, Maria Pelullo, Isabella Screpanti, Maria Pia Felli

Summary: This article reviews the literature on the regulatory role of miRNAs in the immune response of T-ALL, focusing on their roles in Natural Killer, T, T-regulatory, and Myeloid-derived suppressor cells. A better understanding of this molecular crosstalk may provide the basis for the development of potential immunotherapeutic strategies in the field of leukemia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives

Nadezda Zhdanovskaya, Mariarosaria Firrincieli, Sara Lazzari, Eleonora Pace, Pietro Scribani Rossi, Maria Pia Felli, Claudio Talora, Isabella Screpanti, Rocco Palermo

Summary: The Notch signaling pathway plays a context-dependent role in regulating cell fate decisions and has been implicated in both promoting and suppressing tumorigenesis. Targeting Notch signaling shows potential against tumor growth and recurrence, but current strategies face limitations in clinical success due to toxicity and efficacy issues, highlighting the need for novel agents and optimized combinations.

CANCERS (2021)

Article Oncology

Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL

Nadezda Zhdanovskaya, Sara Lazzari, Diego Caprioglio, Mariarosaria Firrincieli, Chiara Maioli, Eleonora Pace, Daniela Imperio, Claudio Talora, Diana Bellavia, Saula Checquolo, Mattia Mori, Isabella Screpanti, Alberto Minassi, Rocco Palermo

Summary: The study shows that curcumin and its derivatives have anti-cancer effects and inhibit Notch signaling in T-ALL cells. These findings suggest the potential of curcumin-based bioactive agents for treating Notch-dependent T-ALL.

CANCERS (2022)

暂无数据